You are hereDecember 4, 2012
STEM CELLS Translational Medicine Selected for Inclusion in MEDLINE
MEDLINE is the premier bibliographic database of journal citations and abstracts for approximately 5,400 biomedical journals worldwide. Access to MEDLINE is freely available through PubMed.
“STEM CELLS Translational Medicine’s inclusion in MEDLINE/PubMed is significant in enhancing the visibility of our authors’ work and to achieving the journal’s vision – to help speed expertly executed translations of emerging lab discoveries into legitimate clinical trials and bedside application which ultimately will improve patient outcomes,” said Managing Editor, Ann Murphy.
“Just as remarkable is the fact that the Journal has been fully accepted by MEDLINE within its first year of publication … a feat that few journals earn,” adds Anthony J. Atala, Editor.
STEM CELLS Translational Medicine, published monthly, is an internationally peer reviewed journal dedicated advancing the clinical utilization of stem cell molecular and cellular biology closer to accepted best practices. The journal can be accessed at www.StemCellsTM.com.
* * *
About STEM CELLS Translational Medicine: STEM CELLS TRANSLATIONAL MEDICINE (SCTM), published by AlphaMed Press, is a monthly peer-reviewed publication dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology. By bridging stem cell research and clinical trials, SCTM will help move applications of these critical investigations closer to accepted best practices.
About AlphaMed Press: Established in 1983, AlphaMed Press with offices in Durham, NC, San Francisco, CA, and Belfast, Northern Ireland, publishes two other internationally renowned peer-reviewed journals: STEM CELLS (www.StemCells.com), celebrating its 30th anniversary in 2012, is the world's first journal devoted to this fast paced field of research. The Oncologist (www.TheOncologist.com), also a monthly peer-reviewed publication, entering its 18th year, is devoted to community and hospital-based oncologists and physicians entrusted with cancer patient care. All three journals are premier periodicals with globally recognized editorial boards dedicated to advancing knowledge and education in their focused disciplines